Idiopathic pulmonary fibrosis (IPF) is an incurable disease with poor prognosis and unknown etiology. The poor clinical outcome is associated with enhanced microbial burden in bronchoalveolar lavage f
‡Significance analysis of microarrays (SAM) of IPF samples when categorized by percent predicted DLCO ≥65% [N = 16]. Differentially- expressed transcripts with 2-fold ch
Fibroblasts are the key effector cells in idiopathic pulmonary fibrosis (IPF), a chronic, progressive scarring disorder that results in impaired gas exchange and respiratory failure. Fibroblasts from
